We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Diatron MI Plc

Develops, manufactures and markets hematology analyzers, clinical chemistry analyzers, and associated reagents for hu... read more Featured Products: More products

Download Mobile App




New Version of 3-Part Differential Hematology Analyzer Launched

By LabMedica International staff writers
Posted on 08 Apr 2014
A new hematology analyzer is particularly suitable for small laboratories, satellite clinics, and doctors’ offices.

Launched by the Diatron Group (Budapest, Hungary) the new Abacus 3CT hematology analyzer is a compact, bench-top, flexible 3-part differential analyzer. It offers 22 parameters thus delivering more patient data, and has a cap piercing capability that enables it to be used with sample tubes that are open or closed.

The new analyzer has been enhanced significantly from the original version. The most visually apparent changes are the introduction of the latest 8” high resolution and the color touch screen with new intuitive multilingual user interface, which makes it clear and simple to operate.

The new Abacus 3CT has an enhanced package of on-board quality control (QC) features. The QC capacity has been greatly increased to 24 lots, and QC values can now be loaded via QR codes or USB to avoid any incorrect assignment of values. Operating rights can also be assigned to selected operators to ensure that only trained persons can use the system. In addition, an on-board log details when reagents were last changed, with a constant on-screen display of reagent expiry dates as well as remaining reagent volumes. Other QC features include aperture anticlog protection and automatic cleaning after every 15 sample measurements.

To accommodate the increased volume of data generated by the 22 parameter measurements, the on-board data storage capacity of the Abacus 3CT has been doubled to 10,000 records, with improved laboratory information system (LIS) connectivity for results transfer.

Diatron develops, manufactures, and markets hematology and clinical chemistry analyzers, and associated reagents for human medical and veterinary use. An R&D/engineering team develops and manufactures a broad product range of products including: hematology analyzers, hematology reagents (both for its own and other manufacturers’ analyzers), hematology control material, clinical chemistry analyzers, clinical chemistry reagents, and clinical chemistry controls.

Related Links:

Diatron Group



Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
H.pylori Test
Humasis H.pylori Card
New
Fecal DNA Extraction Kit
QIAamp PowerFecal Pro DNA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.